Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Penicillin g
Drug ID BADD_D01710
Description Benzylpenicillin (Penicillin G) is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms. Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as *Streptococcus pneumoniae*, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (*S. agalactiae*), *S. viridans*, and *Enterococcus faecalis*. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as *Bacillus anthracis*, *Corynebacterium diphtheriae*, and *Erysipelothrix rhusiopathiae*. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by *Neisseria meningitidis* and *Pasteurella*. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions.
Indications and Usage For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.
Marketing Status approved; vet_approved
ATC Code J01CE01; S01AA14
DrugBank ID DB01053
KEGG ID D02336; D01053
MeSH ID D010400
PubChem ID 5904
TTD Drug ID D00QAR
NDC Product Code 0338-1021; 0338-1023; 0338-1025
UNII Q42T66VG0C
Synonyms Penicillin G | Benzylpenicillin | Coliriocilina | Crystapen | Or-pen | Parcillin | Pekamin | Pengesod | Penibiot | Penicilina G Llorente | Penicillin G Jenapharm | Penicillin G Potassium | Benzylpenicillin Potassium | Penicillin G Sodium | Sodium Penicillin | Sodium Benzylpenicillin | Penicillin Grünenthal | Penilevel | Peniroger | Pfizerpen | Sodiopen | Sodipen | Unicilina | Ursopen | Van-Pen-G | Benpen
Chemical Information
Molecular Formula C16H18N2O4S
CAS Registry Number 61-33-6
SMILES CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Wheezing22.03.01.009--
White blood cells urine positive13.13.02.004---
Tubulointerstitial nephritis20.05.02.002---
Hypoacusis04.02.01.006--
Leukocyturia20.02.01.014---
Musculoskeletal stiffness15.03.05.027---
Protein urine present13.13.02.006---
Musculoskeletal discomfort15.03.04.001---
Injection site swelling08.02.03.017; 12.07.03.0180.076656%-
Haemorrhage24.07.01.002---
Vasodilation procedure25.03.01.001---
Hoigne's syndrome12.02.05.028; 17.02.10.009; 24.01.06.003---
Inflammation08.01.05.007; 10.02.01.089---
Mental disorder19.07.01.002---
Erectile dysfunction19.08.04.001; 21.03.01.007--
Ill-defined disorder08.01.03.049---
Blood disorder01.05.01.004---
Adverse drug reaction08.06.01.0090.009981%-
Psychotic disorder19.03.01.002--
Infusion site irritation08.02.05.010; 12.07.05.0110.013574%-
Treatment failure08.06.01.0170.013574%-
Anal pruritus07.03.03.002---
Hypertransaminasaemia09.01.02.0050.003992%-
Acute kidney injury20.01.03.016--
Injury associated with device08.07.01.012; 12.01.08.0350.015571%-
Sensitisation08.01.05.009; 10.02.01.012---
Gastrointestinal tract irritation07.08.03.008---
Platelet dysfunction01.08.03.003---
Drug reaction with eosinophilia and systemic symptoms10.01.01.021; 12.03.01.064; 23.03.05.0050.007985%-
Coeliac disease07.17.01.008; 10.04.04.012; 14.02.01.007---
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages